425 related articles for article (PubMed ID: 9708542)
21. Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Mori M; Ogawara K; Mizobuchi K; Hattori T; Koga M; Yuki N
Muscle Nerve; 1999 Jul; 22(7):840-5. PubMed ID: 10398200
[TBL] [Abstract][Full Text] [Related]
22. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
[TBL] [Abstract][Full Text] [Related]
23. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
Uncini A; Kuwabara S
Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
[TBL] [Abstract][Full Text] [Related]
24. A-waves in Guillain-Barré syndrome: correlation with electrophysiological subtypes and antiganglioside antibodies.
Kawakami S; Sonoo M; Kadoya A; Chiba A; Shimizu T
Clin Neurophysiol; 2012 Jun; 123(6):1234-41. PubMed ID: 22055840
[TBL] [Abstract][Full Text] [Related]
25. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
26. Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Asahina M; Koga M; Mori M; Yuki N; Hattori T
Neurology; 1998 Dec; 51(6):1656-60. PubMed ID: 9855518
[TBL] [Abstract][Full Text] [Related]
27. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome: an update.
Vucic S; Kiernan MC; Cornblath DR
J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
[TBL] [Abstract][Full Text] [Related]
29. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma.
Hafer-Macko C; Hsieh ST; Li CY; Ho TW; Sheikh K; Cornblath DR; McKhann GM; Asbury AK; Griffin JW
Ann Neurol; 1996 Oct; 40(4):635-44. PubMed ID: 8871584
[TBL] [Abstract][Full Text] [Related]
30. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile.
Yuki N; Kuwabara S; Koga M; Hirata K
J Neurol Sci; 1999 Oct; 168(2):121-6. PubMed ID: 10526194
[TBL] [Abstract][Full Text] [Related]
31. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome.
Hong YH; Sung JJ; Oh MY; Moon HJ; Park KS; Lee KW
J Peripher Nerv Syst; 2011 Mar; 16(1):37-46. PubMed ID: 21504501
[TBL] [Abstract][Full Text] [Related]
32. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
[TBL] [Abstract][Full Text] [Related]
33. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
34. Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.
Kuwabara S; Ogawara K; Koga M; Mori M; Hattori T; Yuki N
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):180-4. PubMed ID: 10406985
[TBL] [Abstract][Full Text] [Related]
35. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
36. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
37. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes.
Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T
Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599
[TBL] [Abstract][Full Text] [Related]
38. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
[TBL] [Abstract][Full Text] [Related]
39. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
[TBL] [Abstract][Full Text] [Related]
40. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
